Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myelomonocytic, Chronic 1Leukemia, Eosinophilic, Acute 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

Cytarabine 23Etoposide 8Daunorubicin 8Idarubicin 7Gene Expression Profiling 6Filgrastim 6tipifarnib 5Gemtuzumab 5Clofarabine 5Peripheral Blood Stem Cell Transplantation 4Mitoxantrone 4Cyclophosphamide 4Sorafenib 3Radiotherapy 3Flow Cytometry 3Busulfan 3Bortezomib 3Arsenic Trioxide 3tanespimycin 2laromustine 2fludarabine phosphate 2eltrombopag 2alvocidib 2aldesleukin 2Thiotepa 2Polymerase Chain Reaction 2Observation 2Microarray Analysis 2Melphalan 2Imatinib Mesylate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Eosinophilic, Acute × palmitoyl-L-asparaginase × Clear all
NCT00369317 2022-01-28

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

Children's Oncology Group

Phase 3 Completed
205 enrolled 19 charts
Other hematologic neoplasm

Leukemia, Eosinophilic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡